Article Details
Retrieved on: 2019-05-18 11:32:43
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
<div><b>Vanguard Group</b> Inc. purchased a new position in shares of Crinetics Pharmaceuticals Inc (NASDAQ:CRNX) in the 3rd quarter, according to the ...</div>
Article found on:
This article is found inside other Hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here